ISSCR News


The ISSCR Holds Inaugural Regulatory Meeting with Japan’s Pharmaceuticals and Medical Devices Agency and South Korea’s Ministry of Food and Drug Safety 
Policy, Announcements Kym Kilbourne Policy, Announcements Kym Kilbourne

The ISSCR Holds Inaugural Regulatory Meeting with Japan’s Pharmaceuticals and Medical Devices Agency and South Korea’s Ministry of Food and Drug Safety 

On 7 November 2024, the International Society for Stem Cell Research (ISSCR) held its first meeting with Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) and Korea’s Ministry of Food and Drug Safety (MFDS). Held at PMDA’s Tokyo headquarters, the meeting brought together senior officials from PMDA and MFDS alongside ISSCR leaders based in Japan, Korea, and the United States.

At this inaugural meeting, participants convened to discuss key topics related to the:

1) manufacture of human Pluripotent Stem Cell (hPSC) banks as starting materials for allogeneic, PSC-based therapies, and
2) genetic assessment of hPSCs, 3) jurisdictional differences in guidelines for biological Ancillary Materials (AM).

The participants also had the opportunity to gain insights into the regulatory approaches of the PMDA and MFDS regarding PSC-based products.  

Read More
ISSCR Joins Coalition Effort to Support Advocacy for NIH Funding
Announcements, Policy Kym Kilbourne Announcements, Policy Kym Kilbourne

ISSCR Joins Coalition Effort to Support Advocacy for NIH Funding

The ISSCR is proud to join a broad coalition of scientific societies in affirming the essential role of the National Institutes of Health in advancing biomedical discovery and sustaining a robust research enterprise. As part of this effort, ISSCR members in the targeted states of Kansas, North Carolina, Pennsylvania, and Utah have been invited to share stories that illustrate the vital importance of research investment. Additional opportunities for members in all states will be available in September. This campaign is led by our alliance partner, Research!America

Read More
The ISSCR Calls for Science Serving the Public Good to be of the Highest Quality and Integrity
Policy, Announcements Kym Kilbourne Policy, Announcements Kym Kilbourne

The ISSCR Calls for Science Serving the Public Good to be of the Highest Quality and Integrity

“The ISSCR joined more than 90 scientific, academic, and professional organizations to emphasize that science serving the public good should be of the highest quality, integrity, and utility. In a letter sent to White House Office of Science and Technology Policy Director Michael Kratsios, signatories urged policymakers to recognize that any efforts to strengthen scientific integrity, including those outlined in the recent Executive Order “Restoring Gold Standard Science”, must build upon, rather than undermine, the existing foundational pillars of gold standard science that have driven decades of scientific and technological progress. These principles, including empirical rigor, objectivity, peer review, and reproducibility have been central to the advancement of stem cell science and the development of cell-based therapies.

Read More
New Podcast Episode. Cancer Neuroscience, Tumor Organoids, and Understanding the Role of the Nervous System in Human Glioblastoma
Announcements Megan Koch Announcements Megan Koch

New Podcast Episode. Cancer Neuroscience, Tumor Organoids, and Understanding the Role of the Nervous System in Human Glioblastoma

The role of neuronal influences on cancer pathogenesis and progression is increasingly appreciated in the nervous system. Neurons have been shown to enhance the proliferation and migration of gliomas, a glial-derived tumor of the CNS, via diffusible paracrine factors or synaptic inputs onto tumor cells. In glioblastomas, a highly aggressive glioma, mostly glutamatergic inputs have been identified. While the potential for glioblastomas to receive projections from neurons of other neurotransmitter subtypes, such as from cholinergic neurons, has recently been discovered in xenotransplantation models, whether synapses can form between human cholinergic neurons and glioblastoma cells and consequences of these inputs and other non-synaptic mechanisms are still unknown.  

 Human induced pluripotent stem cell-based models have been emerging as a powerful platform for studying human-specific disease mechanisms. Today’s guests developed a co-culture model for the study of neuron-tumor interactions by combining patient derived glioblastoma organoids and hiPSC-derived cholinergic neurons. They will discuss their recent findings and what it means for understanding and potentially treating a tumor for which there is no known cure. 

Read More

Receive ISSCR Press Releases

Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications

Subscribe to ISSCR News.

Each month, ISSCR delivers scientific, policy, and community to your inbox .